Novozymes: Acquisition of enzyme activities from Biocon completed
02-Oct-2007
The activities will be integrated into Novozymes' existing Indian and global activities and included in Novozymes' consolidated financial statements with effect from October 1, 2007.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
GENimmune receives Orphan Medicinal Product Designation from European Commission for its hepatitis C monoclonal antibody
Go to page
Allon Therapeutics compounds show potential to repair central nervous system cells after disease or injury
Go to page
Erber-Ludwig & Partner GmbH - München, Germany
Go to page
Marine biotech industry could grow by 12 percent per year - Scientists say innovation inspired by sea life is essential to tackling Europe's grand challenges
Go to page
Lidocaine
Go to page
FDA grants Orphan Drug Status to Allon’s davunetide for brain disease
Go to page
WACKER Expands Production Capacity for Biopharmaceuticals in San Diego - Wacker Biotech US is expanding its mRNA and protein production
Go to page
EPIRUS Biopharmaceuticals, Inc. - Boston, USA
Go to page
ExonHit presents promising first patient results for EHT 0202, its Alzheimer’s candidate drug
Go to page
VASTox provides grant to support Duchenne Muscular Dystrophy patient registry
Go to page
Transition Therapeutics Acquires All Remaining Shares of NeuroMedix Inc.
Go to page
Ablynx initiates Phase I/II trial for ALX-0061 (Anti-IL-6R) in patients with rheumatoid arthritis
Go to page